Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors
- 15 March 1992
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 282 (3) , 909-914
- https://doi.org/10.1042/bj2820909
Abstract
Proteolysis of intact mitochondria by Nagarse (subtilisin BPN') and papain resulted in limited loss of activity of the outer-membrane carnitine palmitoyltransferase, but much greater loss of sensitivity to inhibition by malonyl-CoA. In contrast with a previous report [Murthy & Pande (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 378-382], we found that trypsin had no effect on malonyl-CoA sensitivity. Even when 80% of activity was destroyed by trypsin, there was no difference in the malonyl-CoA sensitivity of the enzyme remaining. Trypsin caused release of the intermembrane-space enzyme adenylate kinase, indicating loss of integrity of the mitochondrial outer membrane, whereas Nagarse and papain caused no release of that enzyme. Citrate synthase was not released by any of the three proteinases, indicating no damage to the mitochondrial inner membrane. When we examined the effects of proteolysis on the inhibition of carnitine palmitoyltransferase by a wide variety of inhibitors having different mechanisms of inhibition, we found differential proteolytic effects that were specific for those inhibitors (malonyl-CoA and hydroxyphenylglyoxylate) that have their inhibitory potencies diminished by changes in physiological state. Both of those inhibitors protected carnitine palmitoyltransferase from the effects of proteolysis, but did not inhibit the proteinases directly. Inhibition by two other inhibitors (DL-2-bromopalmitoyl-CoA and N-benzyladriamycin 14-valerate) was not altered by proteinase treatment, even when most of the enzyme activity had been destroyed. Inhibition by glyburide, which is minimally affected by physiological state, was affected only to a slight extent at the highest concentration of trypsin tested. Proteolysis by Nagarse appeared to produce loss of co-operativity in malonyl-CoA inhibition. The effects of proteolysis are discussed and compared with changes in Ki occurring with changing physiological states.Keywords
This publication has 33 references indexed in Scilit:
- Malonyl-CoA inhibits proteolysis of carnitine palmitoyltransferaseBiochemical and Biophysical Research Communications, 1991
- Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analoguesBiochemical Pharmacology, 1990
- Isovalerylcarnitine is a specific activator of the high calcium requiring calpain formsBiochemical and Biophysical Research Communications, 1990
- CARNITINEAnnual Review of Biochemistry, 1988
- Isovalerylcarnitine is a specific activator of calpain of human neutrophilsBiochemical and Biophysical Research Communications, 1987
- Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane.Proceedings of the National Academy of Sciences, 1987
- Activation of a D‐form of rabbit muscle glycogen synthase by Ca2+‐activated proteaseFEBS Letters, 1986
- Effects of fasting and malonyl CoA on the kinetics of carnitine palmitoyltransferase and carnitine octanoyltransferase in intact rat liver mitochondriaFEBS Letters, 1981
- The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoABiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Regulation of Hepatic Fatty Acid Oxidation and Ketone Body ProductionAnnual Review of Biochemistry, 1980